Tag Archives: Mayo

Chisum Patent Academy Announced 2013 Seminar Dates

Posted on August 22, 2012 by Warren Woessner

This seminar series, taught by Donald Chisum, the leading authority on evolution in patent law, and my former law clerk, Prof. Janice Mueller, explore contemporary developments in patent law in detail. How about a session on how to respond to … Continue reading →

Posted in Conferences and Classes | Tagged chisum patent academy, Donald Chisum, Janice Mueller, Mayo, Myriad | Leave a comment

“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP

Posted on July 9, 2012 by Warren Woessner

A provocative article in the Sunday New York Times recounted how a young cancer researcher, who was diagnosed with acute lymphoblastic leukemia (ALL), and who responded but relapsed twice after receiving chemotherapy and bone marrow transplant, achieved a third remission … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biotechnology law, FLT3, Mayo, Myriad, USPTO, Warren Woessner | Leave a comment

Fed. Cir. Orders Briefing in Myriad Remand

Posted on May 1, 2012 by Warren Woessner

On April 30th, in response to the Supreme Court’s GVR of the Myriad appeal (AMP et al. are still trying to get the claims to isolated DNA molecules and the use of a transgenic cell comprising the BRCA1 gene to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Federal Circuit, Mayo, Myriad, Patent Law, Supreme Court, Warren Woessner | 1 Comment

Federal Circuit Reverses District Court in Prometheus v. Mayo

Posted on September 16, 2009 by Warren Woessner

On September 16, 2009, the Federal Circuit reversed the holding of the district court that a process for monitoring and adjusting a method of medical treatment was unpatentable as attempting to claim non-statutory subject matter (Prometheus Labs., Inc. v. Mayo … Continue reading →